Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

1mon ago, source: Hosted on MSN

Shares of Harrow, Inc. (NASDAQ: HROW) fell sharply in today’s pre-market trading after posting weaker-than-expected fourth-quarter results. Harrow Health posted adjusted loss of 20 cents per ...

Harrow, Inc. (HROW)

6d ago, source: Yahoo Finance

The capital raised will primarily support the further development Harrow Health, Inc. (NASDAQ:HROW) Q4 2023 Earnings Call Transcript March 20, 2024 Harrow Health, Inc. isn’t one of the 30 most ...

Melt Pharmaceuticals raises $24 million for drug development

22d ago, source: The Business Journals

The company is a former subsidiary of Harrow Inc. (Nasdaq: HROW), one of Middle Tennessee’s publicly traded health care companies. Melt Pharmaceuticals became a separately managed business in 2019.

Harrow Stock (NASDAQ:HROW), Analyst Ratings, Price Targets, Predictions

13d ago, source: Benzinga.com

Harrow Inc has a consensus price target of $24.25, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Craig-Hallum, B. Riley Securities ...

Harrow Inc. 8.625% Sr. Notes due 2026

5d ago, source: Wall Street Journal

1 Day HROWL -0.22% DJIA 0.41% Russell 2K 0.28% Health Care/Life Sciences -0.67% ...

Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing

23d ago, source: Stockhouse

Melt Pharmaceuticals, Inc. is a former subsidiary of Harrow, Inc. (Nasdaq: HROW) and was carved out as a separately managed business in 2019. To learn more about Melt, please visit their website, ...

HROWM Harrow, Inc. NT CAL 27

29d ago, source: Seeking Alpha

The security has traded for less than one year There is no Wall Street analyst coverage The security is a closed-end fund or a mortgage REIT The security is listed on a non-US exchange The ...

Opaleye Management Inc. buys $641k of Harrow Inc. common stock

27d ago, source: Investing

Opaleye Management Inc., a significant shareholder in Harrow Inc. (NASDAQ:HROW), has made a notable purchase of the company's common stock, according to the latest filings. The investment firm ...

Harrow Announces New Appointments to its Board of Directors

19d ago, source: ADVFN

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S ...

Harrow Health gets grant for preservative-free ophthalmic composition for dry eye disease

9d ago, source: Pharmaceutical Technology

Discover Harrow Health Inc's innovative patent for preservative-free ophthalmic compositions targeting ocular diseases like dry eye. Learn about the unique formulation stored in a convenient dropper ...

Harrow Partners with Leading Healthcare Market Access Technology Platforms

19d ago, source: ADVFN

For more information about VEVYE, please visit vevye.com. Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ...